Joan M. Lau
Independent TrusteeDr. Joan M. Lau, Ph.D., MBA, is Founding Partner of Militia Hill Ventures since 2013. She serves as an Independent Director at Universal Display Corporation since March 04, 2024. She serves as an Independent Trustee at Brandywine Realty Trust (BDN) since February 01, 2023. She serves as Independent Director of Rockwell Medical, Inc. since October 2023. She is an Independent Director at Renovacor, Inc. since September 2021. Dr. Lau served as Chief Executive Officer of Spirovant (then called Talee Bio). She served as Chief Operating Officer at Immunome, Inc since February 2014. Dr. Lau serves as Chief Executive Officer and President of Ansaris, Inc. She co-founded the nonprofit PhillyBio. Dr. Lau served as Chief Executive Officer and President at Azelon Pharmaceuticals, Inc. Dr. Lau held roles of increasing responsibility in drug discovery and development and business development at Merck & Co., Inc. Dr. Lau served as Chief Executive Officer, Chief Operating Officer and President of Locus Pharmaceuticals, Inc. Dr. Lau worked in the pharmaceuticals and device industry. Prior to Ansaris, Dr. Lau served at Merck & Co. where she served roles of increasing responsibility in R&D Project Management, Portfolio Management and Business Development. During this period, she played significant roles in leading preclinical and early clinical programs and managing the neuroscience drug development portfolio. She managed global business development activities for the Merck Vaccines and Infectious Diseases division. Dr. Lau is also Associate Course Director for the Vagelos Program in Life Sciences Management at the University of Pennsylvani. Dr. Lau served as executive-in-residence at BioAdvance, a funder of life sciences companies in southeastern Pennsylvania. She was responsible to scientific integration in the Office of the President, Merck Research Laboratories. She serves on several boards, including the University of Pennsylvania School of Social Policy and Practice and the Roy & Diana Vagelos Program in Life Sciences Management. Dr. Lau worked in medical device development at Zimmer, Inc. She serves as Member of Advisory Board at BioMotiv, LLC. Additionally, Dr. Lau serves on the Advisory Board for Temple University’s Masters in Biotechnology program. She serves as a Director of Ansaris, Inc. Dr. Lau has MBA from the Wharton School of Business at the University of Pennsylvania. She also has a PhD in Medical Neuroscience from the University of Cincinnati College of Medicine and a BSE degree in Bioengineering from the University of Pennsylvania. She is a director of RiboNova, Inc., a private company. She is a trustee of the Philadelphia Orchestra and Kimmel Center, Inc. She is a trustee of the University of Pennsylvania. Spirovant Sciences Inc. was formerly Talee Bio prior to its acquisition.
公司職務
- 公司名稱Brandywine Realty Trust股票代碼BDN職務Independent Trustee共事同僚
- GHGerard H. SweeneyPresident, CEO & Trustee
- JCJames C. DiggsChair of the Board & Lead Independent Trustee
- TEThomas E. WirthExecutive VP & CFO
- HJH. Jeffrey DeVuonoExecutive VP & Senior MD of Life Sciences
- WDWilliam D. ReddExecutive VP and Senior MD of Austin & Metro DC Regions
- NBNick BecattiniSenior Vice President of Investments & Capital Markets
- CPCharles Peter PizziIndependent Trustee
- HRH. Richard HaverstickIndependent Trustee
- 公司名稱Rockwell Medical, Inc.股票代碼RMTI職務Independent Director共事同僚
- MSMark StrobeckPresident, CEO & Director
- RSRobert Samuel RadieIndependent Chairman
- JNJesse NeriSenior VP & CFO
- MCMegan C. TimminsExecutive VP, Chief Legal Officer & Secretary
- HHHeather H. HunterSenior VP & COO
- NFNicholas FanslauController & Principal Accounting Officer
- JGJohn G. CooperIndependent Director
- ARAllen Richard NissensonIndependent Director
- JMJoan M. LauIndependent Director
